Program Management
Schedules
TAFS: 075-0511 /X - Program Management
| Line # | Split | Description | Iteration 1 Previously Approved Amount | Iteration 2 OMB Action Amount | Footnotes |
|---|---|---|---|---|---|
| 1000 | DE | Discretionary Estimated- Unob Bal: Brought forward, October 1 | $82,000,000 | -$82,000,000 $0 | |
| 1000 | DA | Discretionary Actual- Unob Bal: Brought forward, October 1 | Line added— | +$88,954,054 $88,954,054 | |
| 1000 | ME | Mandatory Estimated - Unob Bal: Brought forward, October 1 | $4,101,431,818 | -$4,101,431,818 $0 | |
| 1000 | MA | Mandatory Actual - Unob Bal: Brought forward, October 1 | Line added— | +$4,266,957,245 $4,266,957,245 | |
| 1740 | BA: Disc: Spending auth:Antic colls, reimbs, other | $30,000,000 | +$1,600,000 $31,600,000 | ||
| 1801 | BA: Mand: Spending auth: Chng uncoll paymt Fed src | $54,569,925 | +$610,173,483 $664,743,408 | See footnotes below | |
| Footnotes for line 1801 (Previous): | B2: Transfer amount has been adjusted to reflect amount sequestered, in the trust funds, pursuant to the OMB Report to the Congress on the Joint Committee Reductions for Fiscal Year 2022. | ||||
| Footnotes for line 1801 (Current): | B2: Transfer amount has been adjusted to reflect amount sequestered, in the trust funds, pursuant to the OMB Report to the Congress on the Joint Committee Reductions for Fiscal Year 2022. | ||||
| 1802 | BA: Mand: Spending auth: Previously unavailable | $93,361,341 | +$2,509,194 $95,870,535 | ||
| 1823 | BA: Mand: Spending auth: New\Unob bal temp reduced | -$135,342,244 | +$29,629,069 -$105,713,175 | ||
| 1840 | BA: Mand: Spending auth:Antic colls, reimbs, other | $2,557,417,097 | -$631,600,000 $1,925,817,097 | ||
| 1920 | Total budgetary resources avail (disc. and mand.) | $6,783,437,937 | +$184,791,227 $6,968,229,164 | See footnotes below | |
| Footnotes for line 1920 (Previous): | B1: These amounts reflect an adjustment to the funds sequestered for FY 2022 pursuant to the FY 2022 Joint Committee sequestration, in accordance with Section 3709(a) of the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), as amended by Public Law 116-260 and further amended by Public Law 117-7, which suspended the sequestration of Medicare programs under tile XVIII of the Social Security Act from May 1, 2020 until December 31, 2021. | ||||
| Footnotes for line 1920 (Current): | B1: These amounts reflect an adjustment to the funds sequestered for FY 2022 pursuant to the FY 2022 Joint Committee sequestration, in accordance with Section 3709(a) of the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), as amended by Public Law 116-260, as amended by Public Law 117-7, and further amended by Public Law 117-71 which suspended the sequestration of Medicare programs under title XVIII of the Social Security Act from May 1, 2020 until March 31, 2022. | ||||
| 6001 | Category A -- 1st quarter | $61,853,860 | $61,853,860 | ||
| 6002 | Category A -- 2nd quarter | $66,371,848 | $66,371,848 | ||
| 6003 | Category A -- 3rd quarter | $52,146,984 | $52,146,984 | ||
| 6004 | Category A -- 4th quarter | $51,164,429 | -$171,884 $50,992,545 | ||
| 6014 | Diagnostic Lab Tests (ACA 3113, P.L. 111-148) | $0 | Line removed— | ||
| 6013 | Extending the Independence at Home Medical Practice Demonstration Program (Sec 105, P.L. 116-260) | $5,000,000 | $5,000,000 | ||
| 6016 | Community Prevention (ACA 4202, P.L. 111-148) | $0 | Line removed— | ||
| 6019 | Provider Enrollment Fees (ACA 6401, P.L.111-148) | $73,177,978 | -$2,701,755 $70,476,223 | ||
| 6017 | GNE Demonstration (ACA 5509, P.L.111-148) | $0 | Line removed— | ||
| 6022 | Nursing Home CMPs (ACA 6111, P.L.111-148) | $6,440,406 | $6,440,406 | ||
| 6018 | Medicare and Medicaid Extenders Act of 2010 (Section 206, P.L. 111-309) | $0 | Line removed— | ||
| 6023 | RAC Retention Fees (MACRA 505, P.L.114-10) | $45,030,000 | $45,030,000 | ||
| 6024 | SHIPS (Consolidated Appropriations Act Sec. 103, P.L. 116-260) | $16,674,159 | $16,674,159 | ||
| 6021 | Medicaid Regulations Study and Report (Section 7001, P.L. 110-252) | $0 | Line removed— | ||
| 6025 | Value-Based Purchasing Program for SNFs (PAMA 215, P.L.113-93) | $125,000 | $125,000 | ||
| 6026 | Clinical Diagnostic Laboratory Test (PAMA 216, P.L.113-93) | $3,825,000 | $3,825,000 | ||
| 6028 | Ensuring Accurate Valuation of Services (PAMA 220, P.L.113-93) | $2,600,000 | $2,600,000 | ||
| 6034 | Repealing SGR and Improving Medicare Payments (MACRA 101, P.L.114-10) | $63,000 | $63,000 | ||
| 6038 | Open Payments CMPs (ACA 6002, P.L.111-148) | $1,307,600 | $1,307,600 | ||
| 6041 | Medicare Site-of-Service (CURES 4011, P.L.114-255) | $1 | -$1 $0 | ||
| 6042 | Medicare Ambulance Services (BBA 50203, P.L.115-123) | $2,616,492 | $2,616,492 | ||
| 6029 | Post-Acute Care Common Measurement Tool (IMPACT 2a, P.L.113-185) | $0 | Line removed— | ||
| 6044 | Recovery Audit Contractors - Part A/B (Section 302, P.L.109-432) | $109,000,000 | -$3,824,196 $105,175,804 | ||
| 6032 | Assessment and Analysis on Adjustments (IMPACT 2d2D, P.L.113-185) | $0 | Line removed— | ||
| 6046 | Recovery Audit Contractors - MSP (Section 302, P.L.109-432) | $50,650,000 | $50,650,000 | ||
| 6048 | Marketplace User Fees (Section 1311&1321, P.L.111-148) | $1,700,000,000 | +$177,529,562 $1,877,529,562 | See footnotes below | |
| Footnotes for line 6048 (Previous): | A4: Of the amounts apportioned on line 6048, $500,000,000 is available immediately for obligation. The remaining $1,200,000,000 is available for obligation 10 days after submission to OMB of an HHS approved spend plan | ||||
| 6049 | Risk Adjustment User Fees (Section 1343, P.L.111-148) | $51,078,621 | +$1,782,755 $52,861,376 | ||
| 6039 | Prohibition of Inclusion of SSNs (MACRA 501, P.L.114-10) | $0 | Line removed— | ||
| 6050 | Extension of Funding for Quality Measure (Consolidated Appropriations Act Sec. 102, P.L. 116-260) | $22,133,917 | +$400,000 $22,533,917 | ||
| 6040 | Treatment of Cancer Hospitals (CURES 16002, P.L.114-255) | $0 | Line removed— | ||
| 6051 | Expanding the Use of Telehealth Services (SUPPORT 2001, P.L.115-271) | $813,197 | $813,197 | ||
| 6053 | Grants to Provide Technical Assistance to Outlier Prescribers (SUPPORT 6052, P.L.115-271) | $2,972,478 | $2,972,478 | ||
| 6055 | Recovery Audit Contractors - Part D (Section 302, P.L. 109-432) | $500,000 | $500,000 | ||
| 6057 | Repeal Medicare Payment Cap Therapy Services (BBA 50202) | $5,000,000 | $5,000,000 | ||
| 6058 | Beneficiary Enrollment Simplification (Consolidated Appropriations Act Sec. 120, P.L. 116-260) | $450,000 | +$356,000 $806,000 | ||
| 6059 | Implementation Funding (Consolidated Appropriations Act Sec. 501, P.L. 116-260) | $16,916,000 | $16,916,000 | ||
| 6060 | Funding for Strike Teams for Resident and Employee Safety SNFs (ARPA Sec 9402, P.L. 117-2) | $250,000,000 | $250,000,000 | ||
| 6061 | Funding for State Strike Teams for Resident and Employee Safety in Nursing Facilities (ARPA Sec 9818 | $250,000,000 | $250,000,000 | ||
| 6062 | Medicare Payment for Rural Emergency Hospital Services (Consolidated Appropriations Act Sec. 125, P. | $3,465,000 | $3,465,000 | ||
| 6063 | Establishing Hospice Program Survey and Enforcement Procedures Under the Medicare Program (Consolida | $9,573,671 | $9,573,671 | ||
| 6054 | Payment Adjustments for Home Health Care (ACA 3131, P.L. 111-148) | $0 | Line removed— | ||
| 6170 | 15 | Apportioned in FY 2023 and future fiscal years - Assessment and Analysis on Adjustments (IMPACT 2d2D | $336,008 | $336,008 | |
| 6170 | 30 | Apportioned in FY 2023 and future fiscal years - Beneficiary Enrollment Simplification (Consolidated | $3,014,734 | +$122,110 $3,136,844 | |
| 6056 | Quality Incentives Computed Tomography (PAMA 218, P.L. 113-93) | $0 | Line removed— | ||
| 6170 | 1 | Apportioned in FY 2023 and future fiscal years - Category A | $209,815,123 | +$50,549,715 $260,364,838 | |
| 6170 | 12 | Apportioned in FY 2023 and future fiscal years - Clinical Diagnostic Laboratory Test (PAMA 216, P.L. | $1,690,039 | +$1,246,192 $2,936,231 | |
| 6170 | 4 | Apportioned in FY 2023 and future fiscal years - Community Prevention (ACA 4202, P.L. 111-148) | $37,978,007 | $37,978,007 | |
| 6170 | 3 | Apportioned in FY 2023 and future fiscal years - Diagnostic Lab Tests (ACA 3113, P.L. 111-148) | $1,250,595 | $1,250,595 | |
| 6170 | 13 | Apportioned in FY 2023 and future fiscal years - Ensuring Accurate Valuation of Services (PAMA 220, | $643,385 | +$1,895,884 $2,539,269 | |
| 6170 | 36 | Apportioned in FY 2023 and future fiscal years - Establishing Hospice Program Survey and Enforcement | Line added— | +$140,548 $140,548 | |
| 6170 | 2 | Apportioned in FY 2023 and future fiscal years - Extending the Independence at Home Medical Practice | $5,898,479 | $5,898,479 | |
| 6170 | 24 | Apportioned in FY 2023 and future fiscal years - Extension of Funding for Quality Measure (Consolida | $2,291,439 | -$136,035 $2,155,404 | |
| 6170 | 5 | Apportioned in FY 2023 and future fiscal years - GNE Demonstration (ACA 5509, P.L.111-148) | $13,998,983 | $13,998,983 | |
| 6170 | 25 | Apportioned in FY 2023 and future fiscal years - Grants to Provide Technical Assistance to Outlier P | $67,303,931 | -$730,198 $66,573,733 | |
| 6170 | 31 | Apportioned in FY 2023 and future fiscal years - Implementation Funding (Consolidated Appropriations | $9,383,691 | +$716,584 $10,100,275 | |
| 6170 | 22 | Apportioned in FY 2023 and future fiscal years - Marketplace User Fees (Section 1311&1321, P.L.111-1 | $1,260,720,821 | -$97,540,648 $1,163,180,173 | |
| 6170 | 8 | Apportioned in FY 2023 and future fiscal years - Medicaid Regulations Study and Report (Section 7001 | $2,854,052 | $2,854,052 | |
| 6170 | 34 | Apportioned in FY 2023 and future fiscal years - Medicare Ambulance Services (BBA 50203, P.L.115-123 | Line added— | +$376,166 $376,166 | |
| 6170 | 6 | Apportioned in FY 2023 and future fiscal years - Medicare and Medicaid Extenders Act of 2010 (Sectio | $5,670,989 | +$1,189,803 $6,860,792 | |
| 6170 | 32 | Apportioned in FY 2023 and future fiscal years - Medicare Payment for Rural Emergency Hospital Servi | $5,035,000 | +$372,984 $5,407,984 | |
| 6170 | 33 | Apportioned in FY 2023 and future fiscal years - Medicare Site-of-Service (CURES 4011, P.L.114-255) | Line added— | +$256,414 $256,414 | |
| 6170 | 9 | Apportioned in FY 2023 and future fiscal years - Nursing Home CMPs (ACA 6111, P.L.111-148) | $75,034,463 | +$13,102,997 $88,137,460 | |
| 6170 | 17 | Apportioned in FY 2023 and future fiscal years - Open Payments CMPs (ACA 6002, P.L.111-148) | $1,213,639 | $1,213,639 | |
| 6170 | 26 | Apportioned in FY 2023 and future fiscal years - Payment Adjustments for Home Health Care (ACA 3131, | $463,500,000 | $463,500,000 | See footnotes below |
| Footnotes for line 6170 (26) (Previous): | A3: Of the amounts apportioned on line 6054, $463,500,000 corresponds to section 3131(d) of the Patient Protection and Affordable Care Act and the legal availability of these amounts is the subject of a continuing legal review, consistent with OMB section 120.9. After resolution is reached, the account will be reapportioned accordingly. | ||||
| Footnotes for line 6170 (26) (Current): | A3: Of the amounts apportioned on line 6054, $463,500,000 corresponds to section 3131(d) of the Patient Protection and Affordable Care Act and the legal availability of these amounts is the subject of a continuing legal review, consistent with OMB section 120.9. After resolution is reached, the account will be reapportioned accordingly. | ||||
| 6170 | 14 | Apportioned in FY 2023 and future fiscal years - Post-Acute Care Common Measurement Tool (IMPACT 2a, | $1,581,839 | +$37,222 $1,619,061 | |
| 6170 | 18 | Apportioned in FY 2023 and future fiscal years - Prohibition of Inclusion of SSNs (MACRA 501, P.L.11 | $11,075,709 | $11,075,709 | |
| 6170 | 7 | Apportioned in FY 2023 and future fiscal years - Provider Enrollment Fees (ACA 6401, P.L.111-148) | $15,827,773 | -$7,931,275 $7,896,498 | |
| 6170 | 28 | Apportioned in FY 2023 and future fiscal years - Quality Incentives Computed Tomography (PAMA 218, P | $14,518,320 | $14,518,320 | |
| 6170 | 10 | Apportioned in FY 2023 and future fiscal years - RAC Retention Fees (MACRA 505, P.L.114-10) | $237,695,228 | +$25,943,414 $263,638,642 | |
| 6170 | 21 | Apportioned in FY 2023 and future fiscal years - Recovery Audit Contractors - MSP (Section 302, P.L. | $731,697,752 | -$49,658,051 $682,039,701 | |
| 6170 | 20 | Apportioned in FY 2023 and future fiscal years - Recovery Audit Contractors - Part A/B (Section 302, | $672,811,291 | +$43,897,552 $716,708,843 | |
| 6170 | 27 | Apportioned in FY 2023 and future fiscal years - Recovery Audit Contractors - Part D (Section 302, P | $1,912,453 | $1,912,453 | |
| 6170 | 29 | Apportioned in FY 2023 and future fiscal years - Repeal Medicare Payment Cap Therapy Services (BBA 5 | $19,465,378 | +$70,274 $19,535,652 | |
| 6170 | 16 | Apportioned in FY 2023 and future fiscal years - Repealing SGR and Improving Medicare Payments (MACR | $7,336,647 | -$16,167 $7,320,480 | |
| 6170 | 23 | Apportioned in FY 2023 and future fiscal years - Risk Adjustment User Fees (Section 1343, P.L.111-14 | $36,943,228 | +$27,279,809 $64,223,037 | |
| 6170 | 35 | Apportioned in FY 2023 and future fiscal years - SHIPS (Consolidated Appropriations Act Sec. 103, P. | Line added— | +$235,452 $235,452 | |
| 6170 | 19 | Apportioned in FY 2023 and future fiscal years - Treatment of Cancer Hospitals (CURES 16002, P.L.114 | $1,968,433 | $1,968,433 | |
| 6170 | 11 | Apportioned in FY 2023 and future fiscal years - Value-Based Purchasing Program for SNFs (PAMA 215, | $2,020,867 | $2,020,867 | |
| 6190 | Total budgetary resources available | $6,783,437,937 | +$184,791,227 $6,968,229,164 | See footnotes below | |
| Footnotes for line 6190 (Previous): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | ||||
| Footnotes for line 6190 (Current): | A1: Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. A2: The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. | ||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A3 | Of the amounts apportioned on line 6054, $463,500,000 corresponds to section 3131(d) of the Patient Protection and Affordable Care Act and the legal availability of these amounts is the subject of a continuing legal review, consistent with OMB section 120.9. After resolution is reached, the account will be reapportioned accordingly. |
| B1 | These amounts reflect an adjustment to the funds sequestered for FY 2022 pursuant to the FY 2022 Joint Committee sequestration, in accordance with Section 3709(a) of the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), as amended by Public Law 116-260, as amended by Public Law 117-7, and further amended by Public Law 117-71 which suspended the sequestration of Medicare programs under title XVIII of the Social Security Act from May 1, 2020 until March 31, 2022. |
| B2 | Transfer amount has been adjusted to reflect amount sequestered, in the trust funds, pursuant to the OMB Report to the Congress on the Joint Committee Reductions for Fiscal Year 2022. |
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | Details on attachments are not subject to 31 USC 1517. The term "attachments" includes but is not limited to the worksheets in this excel file that accompany the SF 132 and this footnote worksheet. |
| A2 | The total amount apportioned may be increased for additional spending authority from offsetting collections received by an amount not to exceed 10% of the sum of such amounts identified in the calculation of total budgetary resources available (excluding appropriations from the Medicare trust funds). The amount of such increase is to be applied to the appropriate line in the application of budgetary resources. |
| A3 | Of the amounts apportioned on line 6054, $463,500,000 corresponds to section 3131(d) of the Patient Protection and Affordable Care Act and the legal availability of these amounts is the subject of a continuing legal review, consistent with OMB section 120.9. After resolution is reached, the account will be reapportioned accordingly. |
| A4 | Of the amounts apportioned on line 6048, $500,000,000 is available immediately for obligation. The remaining $1,200,000,000 is available for obligation 10 days after submission to OMB of an HHS approved spend plan |
| B1 | These amounts reflect an adjustment to the funds sequestered for FY 2022 pursuant to the FY 2022 Joint Committee sequestration, in accordance with Section 3709(a) of the Coronavirus Aid, Relief, and Economic Security Act ("CARES Act"), as amended by Public Law 116-260 and further amended by Public Law 117-7, which suspended the sequestration of Medicare programs under tile XVIII of the Social Security Act from May 1, 2020 until December 31, 2021. |
| B2 | Transfer amount has been adjusted to reflect amount sequestered, in the trust funds, pursuant to the OMB Report to the Congress on the Joint Committee Reductions for Fiscal Year 2022. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.